Phenylephrine-Induced Neurogenic Prostatitis Facilitates the Promotion of PIN-Like Lesions in Rats

Prostate

Volumn 59, Issue 1, 2004, Pages 107-113

  Rosenzweig, Nurit ^a   Horodniceanu, J ^a   Abramovici, A ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Dysplastic changes; Inflammatory exudate; Prostate

Indexed keywords

CELL MARKER; FORMALDEHYDE; PARAFFIN; PHENYLEPHRINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA IN SITU; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE TIME EFFECT RELATION; EDEMA; EUTHANASIA; EXUDATE; FIBROSIS; HEALING; HYPEREMIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MAST CELL; NEUROGENIC PROSTATITIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATITIS; RAT; VASODILATATION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; EXUDATES AND TRANSUDATES; IMMUNOHISTOCHEMISTRY; MALE; PHENYLEPHRINE; PROSTATIC HYPERPLASIA; PROSTATITIS; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 1642349374     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10355     Document Type: Article

References (35)

1. Nemeth J, Lee C. Prostatic ductul system in rats: Regional variation in stromal organization. Prostate 1996;28:124-128.
2. Baumgarten HG, Falck B, Holstein AF, Owman C, Owman T. Adrenergic innervation of the human testis, epididymis, ductus deferens, and prostate: A fluorescence microscopic and fluorimetric study. Z Zellforsch Mikrosk Anat 1968;90:81-95.
3. Elbadawi A, Goodman DC. Autonomic innervation of accessory male genital glands. In: Spring-Mills E, Hafez SEE, editors. Male accessory sex gland. Amsterdam: Elsevier, North Holland Biomedical Press; 1980. p 101.
4. McVary KT, McKenna KE, Lee C. Prostate innervation. Prostate Suppl 1998;8:2-13.
5. Lepor H, Tang R, Meretyk S, Shapiro E. Binding and functional properties of alpha 1 adrenoceptor in different regions of the human prostate. J Urol 1993;150:253-256.
6. Hoffman BB. Adrenoceptor-activating & other sympathomimetic drugs. In: Katzung GB, editor. Basic & clinical pharmacology. 8th edn. New York: McGraw-Hill Co; 2001. pp 120-137.
7. Smith P, Rhodes NP, Beesley C, Ke Y, Foster CS. Prostatic stromal cell phenotype is directly modulated by norepinephrine. Urology 1998;51:663-670.
8. Golomb E, Kruglikova A, Dvir D, Parnes N, Abramovici A. Induction of atypical prostatic hyperplasia in rats by sympathomimetic stimulation. Prostate 1998;34:214-221.
9. Magee JC, Schofield GG. Alteration of synaptic transmission in sympathetic ganglia of spontaneously hypertensive rats. Am J Physiol 1994;267:1397-1407.
10. Golomb E, Rosenzweig N, Eilam R, Abramovici A. Spontaneous hyperplasia of the ventral lobe of the prostate in aging genetically hypertensive rats. J Androl 2000;21:58-64.
11. Boyle P, Napalkov P. The epidemiology of benign prostatic hyperplasia and observation on concomitant hypertension. Scand J Urol Nephrol 1995;168:7-12.
12. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate. Am J Pathol 1999;155:1985-1992.
13. Sheehan D, Hrapchak B. Theory and practice of histotechnology. 2nd edn. Ohio: Battelle Press; 1980. p 282.
14. Anim JT, Udo C, John B. Characterization of inflammatory cells in benign prostatic hyperplasia. Acta Histochem 1998;100:439-449.
15. Hammel I, Roizman P, Massas R, Abramovici A. Ontogeny of mast cells in the ventral prostate of the rat. Int Arch Allergy Appl Immunol 1990;93:212-215.
16. Bauer ME, Perks P, Lightman SL, Shanks N. Are adhesion molecules involved in stress-induced changes in lymphocyte distribution? Life Sci 2001;69:1167-1179.
17. Gahmberg CG, Valmu L, Fagerholm S, Kotovuori P, Ihanus E, Tian L, Pessa-Morikawa T. Leukocyte integrins and inflammation. Cell Mol Life Sci 1998;54:549-555.
18. Gatenbeck L, Aronsson A, Dahlgren S, Johansson B, Stromberg L. Stress stimuli-induced histopathological changes in the prostate: An experimental study in the rat. Prostate 1987;11:69-76.
19. Cotran RS, Kumar V, Robbins SL, editors. Robbins pathologic basis of diseases. 5th edn. Philadelphia: W.B. Saunders; 1994. p 74.
20. Hogaboam CM, Steinhauser ML, Chensue SW, Kunkel SL. Novel roles for chemokines and fibroblasts in interstitial fibrosis. Kidney Int 1998;54:2152-2159.
21. Yamate J, Sato K, Ide M, Nakanishi M, Kuwamura M, Sakuma S, Nakatsuji S. Participation of different macrophage populations and myofibroblastic cells in chronically developed renal interstitial fibrosis after cisplatin-induced renal injury in rats. Vet Pathol 2002;39:322-333.
22. Robinette CL. Sex-hormone-induced inflammation and fibromuscular proliferation in the rat lateral prostate. Prostate 1988;12:271-286.
23. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2001;53:31-47.
24. Galli SJ. New concepts about the mast cell. New Engl J Med 1993;328:257-265.
25. Morton CR, Chahl LA. Pharmacology of the neurogenic oedema response to electrical stimulation of the saphenous nerve in the rat. Naunyn Schmiedebergs Arch Pharmacol 1980;314:271-276.
26. Ekblad E, Edvinsson L, Wahlestedt C, Uddman R, Hakanson R, Sundler F. Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pep 1984;8:225-235.
27. Nilsson J, von Euler AM, Dalsgaard CJ. Stimulation of connective tissue cell growth by substance P and substance K. Nature 1985;315:61-63.
28. Kohnen PW, Drach GW. Patterns of inflammation in prostatic hyperplasia: A histologic and bacteriologic study. J Urol 1979;121:755-760.
29. McClinton S, Miller ID, Eremin O. An immunohistochemical characterisation of the inflammatory cell infiltrate in benign and malignant prostatic disease. Br J Cancer 1990;61:400-403.
30. Gleason PE, Jones JA, Regan JS, Salvas DB, Eble JN, Lamph WW, Vlahos CJ, Huang WL, Falcone JF, Hirsch KS. Platelet derived growth factor (PDGF), androgens, and inflammation: Possible etiologic factors in the development of prostatic hyperplasia. J Urol 1993;149:1586-1592.
31. Kessler OJ, Keisari Y, Servadio C, Abramovici A. Role of chronic inflammation in the promotion of prostatic hyperplasia in rats. J Urol 1998;159:1049-1053.
32. McNeal JE, Bostwick DG. Intraductal dysplasia: A premalignant lesion of the prostate. Hum Pathol 1986;17:64-71.
33. Bostwick DG, Srigley J, Grignon D, Maksem J, Humphrey P, van der Kwast TH, Bose D, Harrison J, Young RH. Atypical adenomatous hyperplasia of the prostate: Morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol 1993;24:819-832.
34. Epstein JI. Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. Hum Pathol 1995;26:223-229.
35. Kronz JD, Allan CH, Shaikh AA, Epstein JI. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: Data on men with more than one follow-up biopsy. Am J Surg Pathol 2001;25:1079-1085.